Over 6000 rare diseases are characterised by a wide spectrum of symptoms that differ not only from disease to disease but also from patient to patient. Generally widespread symptoms can mask rare diseases, causing misdiagnosis and delaying treatment. Learn more about rare diseases on this Rare Disease Day by joining us live with Dr. Naresh Gupta, Advisor for Hemophilia at HDCC, Dr. Priyanka Samal, Head of the Department of Clinical Hematology & Stem Cell Transplant at IMS & SUM Hospital & Medical College in Bhubaneswar and Dr. M. Vijayakumar, Professor of Paediatrics at Kozhikode Medical College!

Indian Perspective on Rare Diseases

Extended half-life (EHL) recombinant factor VIII drugs promise excellent prophylaxis by reducing dose frequency, enhancing compliance, and improving quality of life while maintaining safety and efficacy. This session will provide a detailed overview of the rationale for developing EHL coagulation factors and their use in the treatment of haemophilia A, with a focus on the indications, efficacy, and safety of the existing EHL-FVIII products.

Emerging role of EHL FVIII in Hemophilia A Mx with better clinical outcomes

In India, hemophilia goes undiagnosed because of a lack of awareness and poor public infrastructure for detection. Roche, a global leader in the pharmaceutical industry, will take you through the broad classification of the condition, its clinical presentations, and the coagulation cascade underlying the process of clotting. Additionally, the session aims to cover the clinical interpretation of PT, aPTT, and TT and provide a detailed overview of Hemophilia A, from prevention to treatment. Join us live and exclusive on Medflix for this fascinating session!

Your Practice & Hemophilia

Advisor for Hemophilia, Govt. of NCT Delhi and Medical Consultant, Maulana Azad Medical College, New Delhi

Dr. Naresh Gupta

3

808

14.4K

4.6

Sessions Taken

364

4.5

225

4.5

339

4.6